PCAR
56
-5
ILMN
32
-9
GRMN
67
-4
OI
42
-3
RRC
52
-6
COP
57
-2
EXPD
43
-4
AME
74
-4
NOV
52
-5
MUR
44
-3
EQR
54
3
DTE
43
5
HSIC
45
5
DFS
64
2
BSX
64
-3
AMZN
61
-5
WBA
43
-4
URI
60
-6
AMT
37
3
K
51
-3
PCAR
56
-5
ILMN
32
-9
GRMN
67
-4
OI
42
-3
RRC
52
-6
COP
57
-2
EXPD
43
-4
AME
74
-4
NOV
52
-5
MUR
44
-3
EQR
54
3
DTE
43
5
HSIC
45
5
DFS
64
2
BSX
64
-3
AMZN
61
-5
WBA
43
-4
URI
60
-6
AMT
37
3
K
51
-3
Financhill
Back

ProShares UltraShort Nasdaq Biotech Stock Predictions

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.
Buy
58

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
17.67
Seasonality Move:
-11.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

ProShares UltraShort Nasdaq Biotech Stock Forecast

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotech has on average historically fallen by 29.2% based on the past 14 years of stock performance.
  • ProShares UltraShort Nasdaq Biotech has fallen lower in 13 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 92.86%
  • Is ProShares UltraShort Nasdaq Biotech Stock Undervalued?
    The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $17.68. The Score for BIS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • BIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will ProShares UltraShort Nasdaq Biotech Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotech has on average historically fallen by 29.2% based on the past 14 years of stock performance.

ProShares UltraShort Nasdaq Biotech Stock Rating

Buy
58
ProShares UltraShort Nasdaq Biotech (BIS) is a Buy

Is ProShares UltraShort Nasdaq Biotech overpriced?

  • ProShares UltraShort Nasdaq Biotech has fallen lower in 13 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 92.86%

ProShares UltraShort Nasdaq Biotech Stock Price History

Is BIS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
24.63
52-Week Low:
14.05

Prediction Charts

Market Cap:
0
Price in USD:
17.68
Volume:
44.41K
Beta:
-1.62

Technical Analysis

SMA50:
15.19
SMA100:
15.24
SMA200:
16.65
52-Wk Change:
-27.54%

Stock Predictions

  • Is ProShares UltraShort Nasdaq Biotech stock public?
    Yes, ProShares UltraShort Nasdaq Biotech is a publicly traded company.
  • What is the ProShares UltraShort Nasdaq Biotech stock quote today?
    The ProShares UltraShort Nasdaq Biotech stock price is 17.68 USD today.
  • How to buy ProShares UltraShort Nasdaq Biotech stock online?
    You can buy ProShares UltraShort Nasdaq Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 15.32 15.32 15.34 15.32
Oct-30 15.50 15.49 15.50 15.33
Oct-31 15.89 15.96 15.96 15.75
Nov-1 15.82 15.54 15.82 15.54
Nov-4 15.47 15.50 15.76 15.39
Nov-5 15.62 15.19 15.65 15.18
Nov-6 14.71 14.92 15.11 14.71
Nov-7 14.76 14.54 14.76 14.46
Nov-8 14.41 14.35 14.42 14.33
Nov-11 14.27 14.43 14.43 14.10
Nov-12 14.57 15.24 15.23 14.57
Nov-13 14.95 15.48 15.46 14.93
Nov-14 15.78 16.22 16.23 15.76
Nov-15 16.45 17.68 17.70 16.45

ProShares UltraShort Nasdaq Biotech Earnings

Data Unavailable

ProShares UltraShort Nasdaq Biotech Forecast Revenue Growth

Data Unavailable

* ProShares UltraShort Nasdaq Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.